Combination or sequential teriparatide for osteoporosis treatment in denosumab-users: real-world bone mineral density outcomes
The optimal osteoanabolic strategy in denosumab (Dmab)-users remains uncertain. In treatment-naïve patients, Dmab/teriparatide (TPTD) combinations result in dramatic bone mineral density (BMD) gains at the spine and hip. However, BMD outcomes with combination Dmab/TPTD have not been investigated in...
Saved in:
| Main Authors: | Shejil KUMAR, Courtney STREETER, Michelle M. MCDONALD, Roderick J. CLIFTON- BLIGH, Matti L. GILD, Christian M. GIRGIS |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Bone Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352187225000245 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative efficacy of teriparatide and bisphosphonates or denosumab vs. teriparatide monotherapy in osteoporosis: a meta-analysis
by: Huan Jin, et al.
Published: (2025-05-01) -
Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of male osteoporosis: a systematic review and Bayesian network meta-analysis
by: Liangshi Chen, et al.
Published: (2025-04-01) -
Current treatment of osteoporosis
by: Subramanian Nallasivan
Published: (2019-01-01) -
The efficacy and safety of denosumab, risedronate, alendronate and teriparatide to treat male osteoporosis: a systematic review and bayesian network meta-analysis
by: Shu Jun Chai, et al.
Published: (2025-06-01) -
Impacts of Prior Anti-Osteoporosis Treatments on Sequential Denosumab Responses in BMD Changes Among Postmenopausal Osteoporosis Women in East China: Real-World Data Analysis
by: Guan G, et al.
Published: (2025-05-01)